APP and Alzheimer disease: To further elucidate the role of CTSS in the pathogenesis of AD, we used APP/PS1 transgenic mice as the AD model mice and reduced CTSS expression through stereotactic injection of the CTSS selective inhibitor LY3000328 using an implanted cannula in the hippocampus.